Works matching IS 09291903 AND DT 2009 AND VI 16 AND IP 4

Results: 10

Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 4, p. 351, doi. 10.1038/cgt.2008.78

By:

Pu, P.;
Zhang, Z.;
Kang, C.;
Jiang, R.;
Jia, Z.;
Wang, G.;
Jiang, H.

Publication type:

Article

Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 4, p. 362, doi. 10.1038/cgt.2008.80

By:

Sonabend, A. M.;
Ulasov, I. V.;
Han, Y.;
Rolle, C. E.;
Nandi, S.;
Cao, D.;
Tyler, M. A.;
Lesniak, M. S.

Publication type:

Article

Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 4, p. 291, doi. 10.1038/cgt.2008.83

By:

Kulu, Y.;
Dorfman, J. D.;
Kuruppu, D.;
Fuchs, B. C.;
Goodwin, J. M.;
Fujii, T.;
Kuroda, T.;
Lanuti, M.;
Tanabe, K. K.

Publication type:

Article

Reovirus infection of cancer cells is not due to activated Ras pathway.

Published in:

2009

By:

Song, L.;
Ohnuma, T.;
Gelman, I. H.;
Holland, J. F.

Publication type:

Letter

Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 4, p. 310, doi. 10.1038/cgt.2008.85

By:

Tosch, C.;
Geist, M.;
Ledoux, C.;
Ziller-Remi, C.;
Paul, S.;
Erbs, P.;
Corvaia, N.;
Von Hoegen, P.;
Balloul, J.-M.;
Haegel, H.

Publication type:

Article

Translational strategies exploiting TNF-α that sensitize tumors to radiation therapy.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 4, p. 373, doi. 10.1038/cgt.2008.86

By:

Mauceri, H. J.;
Beckett, M. A.;
Liang, H.;
Sutton, H. G.;
Pitroda, S.;
Galka, E.;
Efimova, E.;
Darga, T.;
Khodarev, N. N.;
King, C. R.;
Posner, M. C.;
Hellman, S.;
Kufe, D. W.;
Weichselbaum, R. R.

Publication type:

Article

Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 4, p. 320, doi. 10.1038/cgt.2008.87

By:

Gentschev, I.;
Stritzker, J.;
Hofmann, E.;
Weibel, S.;
Yu, Y. A.;
Chen, N.;
Zhang, Q.;
Bullerdiek, J.;
Nolte, I.;
Szalay, A. A.

Publication type:

Article

Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 4, p. 329, doi. 10.1038/cgt.2008.88

By:

Lortal, B;
Gross, F.;
Peron, J. M.;
Pénary, M.;
Berg, D.;
Hennebelle, I.;
Favre, G.;
Couderc, B.

Publication type:

Article

High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 4, p. 338, doi. 10.1038/cgt.2008.89

By:

Grinshtein, N.;
Ventresca, M.;
Margl, R.;
Bernard, D.;
Yang, T-C.;
Millar, J. B.;
Hummel, J.;
Beermann, F.;
Wan, Y.;
Bramson, J. L.

Publication type:

Article

PDGF-A promoter and enhancer elements provide efficient and selective antineoplastic gene therapy in multiple cancer types.

Published in:

Cancer Gene Therapy, 2009, v. 16, n. 4, p. 298, doi. 10.1038/cgt.2008.92

By:

Mishra, A.;
Ormerod, A. K.;
Cibull, M. L.;
Spear, B. T.;
Kraner, S. D.;
Kaetzel, D. M.

Publication type:

Article